Comparison

MEFV (Mediterranean fever)

Manufacturer GENWAY
Category
Type Antibody
Specific against other
Applications WB
Amount 0.1 mg
Item no. 18-003-42140
eClass 6.1 32160702
eClass 9.0 32160702
Available
Genway ID:
GWB-C69E40
Antigen Specificity:
Polyclonal antibody produced in rabbits immunized with a synthetic peptide corresponding to a region of Human MEFV.
Immunogen:
TPSDHLLSTLEELVPYDFEKFKFKLQNTSVQKEHSRIPRSQIQRARPVKM
Immunogen:
Lyophilized powder
Handling:
Add 100ul off distilled water to this antibody before use.
ELISA Titre:
1:62500Western Blot: Antibody
Dilution:
0. 625ug/mlPeptide
Sequence:
TPSDHLLSTLEELVPYDFEKFKFKLQNTSVQKEHSRIPRSQIQRARPVKM
Note:
Suggested starting concentrations are provided. Optimal dilutions should be determined by end-user. Differences in calculated versus apparent molecular weight may be due to post-translational modifications or protein hydrophobicity. MEFV was identified as the gene that when mutated causes Mediterranean fever. a hereditary periodic fever syndrome. MEFV is expressed in granulocytes and myeloid bone marrow precursors.
Function:
Probably controls the inflammatory response in myelomonocytic cells at the level of the cytoskeleton organization.
Subunit:
Interacts with PSTPIP1.
Subcellular Location:
Isoform 1: Cytoplasm cytoskeleton. Note=Associated with microtubules and with the filamentous actin of perinuclear filaments and peripheral lamellar ruffles.
Subcellular Location:
Isoform 2: Nucleus.
Tissue Specificity:
Expressed in peripheral blood leukocytes particularly in mature granulocytes and to a lesser extent in monocytes but not in lymphocytes. Detected in spleen lung and muscle probably as a result of leucocyte infiltration in these tissues. Not expressed in thymus prostate testis ovary small intestine colon heart brain placenta liver kidney pancreas. Expression detected in several myeloid leukemic colon cancer and prostate cancer cell lines. Developmental Stage: First detected in bone marrow promyelocytes. Expression increases throughout myelocyte differentiation and peaks in the mature myelomonocytic cells.
Induction:
In monocytes by treatment with colchicine and IFN-alpha and by the proinflammatory cytokines IFN-gamma TNF-alpha and LPS. Repressed in monocytes by the antiinflammatory cytokines IL-10 TGF-beta and IL-4. In neutrophils colchicine TNF-alpha LPS IL-10 INF-alpha and IL-4 has no effect on expression. INF-gamma increases expression in neutrophils.
Disease:
Defects in MEFV are the cause of familial Mediterranean fever autosomal recessive (ARFMF) [MIM:249100]. ARFMF is an inherited disorder characterized by recurrent episodic fever serosal inflammation and pain in the abdomen chest or joints. ARFMF is frequently complicated by amyloidosis which leads to renal failure and can be prophylactically treated with colchicine. ARFMF primarily affects ancestral ethnic groups living around the Mediterranean basin: North African Jews Armenians Arabs and Turks. The disease is also distributed in other populations including Greeks Cypriots Italians and Spanish although at a lower prevalence.
Disease:
Defects in MEFV are the cause of familial Mediterranean fever autosomal dominant (ADFMF) [MIM:134610]. ADFMF is characterized by periodic fever serosal inflammation and pain in the abdomen chest or joints as seen also in the autosomal recessive form of the disease. It is associated with renal amyloidosis and characterized by colchicine unresponsiveness.
Similarity:
Contains 1 B box-type zinc finger.
Similarity:
Contains 1 B30. 2/SPRY domain.
Similarity:
Contains 1 DAPIN domain. Summary: MEFV was identified as the gene that when mutated causes Mediterranean fever a hereditary periodic fever syndrome. MEFV is expressed in granulocytes and myeloid bone marrow precursors. Giaglis. S. . et al. . (2006) Dig. Dis. Sci. 51 (4). 687-692.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Delivery expected until 6/13/2024 

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close